| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/09/1997 | US5665743 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD] indoles |
| 09/09/1997 | US5665741 1,4-dihydropyridine-3,5-dicarboxylic acid esters in treatment of neuronal diseases |
| 09/09/1997 | US5665740 Isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1, 4-dihydro-2,6-dimethyl-pyridine-3,5-dica rboxylate |
| 09/09/1997 | US5665738 Imidazole derivatives and processes for the preparation thereof |
| 09/09/1997 | US5665729 Carbocyclic or heterocyclic fused dihydropyridines |
| 09/09/1997 | US5665719 Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists |
| 09/09/1997 | US5665365 Formulations containing coumarins and the use thereof in the pharmaceutical and cosmetic fields |
| 09/04/1997 | WO1997031949A1 Antibodies binding to monocyte chemoattractant protein 1 (mcp-1) receptor (ccr2) |
| 09/04/1997 | WO1997031941A2 Soluble tachykinin antagonists, the preparation and use thereof |
| 09/04/1997 | WO1997031939A1 Serine protease inhibitors |
| 09/04/1997 | WO1997031937A1 Serine protease inhibitors |
| 09/04/1997 | WO1997031907A1 Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma |
| 09/04/1997 | WO1997031902A1 Quinoxaline derivatives useful in therapy |
| 09/04/1997 | WO1997031895A2 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 09/04/1997 | WO1997031654A1 Nitric oxide donors capable of reducing toxicity from drugs |
| 09/04/1997 | WO1997031636A1 Novel indole and benzothiazole derivatives |
| 09/04/1997 | WO1997031634A1 At1 receptor antagonist for the stimulation of apoptosis |
| 09/04/1997 | WO1997031625A1 Inhibition of selectin binding |
| 09/04/1997 | CA2247802A1 Soluble tachykinin antagonists, the preparation and use thereof |
| 09/04/1997 | CA2247208A1 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 09/04/1997 | CA2246813A1 Novel indole and benzothiazole derivatives |
| 09/04/1997 | CA2246722A1 Serine protease inhibitors |
| 09/04/1997 | CA2246246A1 Serine protease inhibitors |
| 09/04/1997 | CA2198980A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 09/04/1997 | CA2198979A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 09/03/1997 | EP0792883A1 Novel derivates of boronic acid, process for their preparation and pharmaceutical compositions containing them |
| 09/03/1997 | EP0792874A1 Quinoxaline derivatives useful in therapy |
| 09/03/1997 | EP0792643A1 Use of an aldose reductase inhibitor for reducing non-cardiac tissue damage |
| 09/03/1997 | EP0792642A1 Method of treating conditions with estrogen agonists |
| 09/03/1997 | EP0792370A1 INTERLEUKIN-1 $g(b) CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-3 AND 4 |
| 09/03/1997 | EP0792292A2 Orphan receptor |
| 09/03/1997 | EP0792278A1 Tumor necrosis factor-gamma |
| 09/03/1997 | EP0792268A1 Hypolipidemic benzothiazepines |
| 09/03/1997 | EP0792265A1 Endothelin antagonists |
| 09/03/1997 | EP0792264A1 Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 09/03/1997 | EP0792156A1 Methods for the prevention or treatment of vascular hemorrhaging and alzheimer's disease |
| 09/03/1997 | EP0687256B1 Hydroxymethyl furazane carboxylic acid derivatives and their use in the treatment of cardio-vascular conditions |
| 09/03/1997 | EP0656905B1 Calcium channel blocking polypeptide from agelenopsis aperta |
| 09/03/1997 | EP0639178B1 Anti-atherosclerotic aryl compounds |
| 09/03/1997 | CN1158624A Gas phase polymerization process |
| 09/03/1997 | CN1158615A Bicyclic carboxamides as 5-ht1A antagonists |
| 09/03/1997 | CN1158613A Novel use and noveld erivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
| 09/03/1997 | CN1158606A Benzoylaguanidine derivatives as medicaments |
| 09/03/1997 | CN1158568A 2,3-dihydro-1-1(2,2,2-trifluoroethyl)-2-oxo-5-phenyl-1H-1,4-benzodiazepines |
| 09/03/1997 | CN1035768C 2,19-methyleneoxy and 2,19-methylenethio bridged steroids as aromatase and 19-hydroxylase |
| 09/02/1997 | US5663414 Inhibits phospholipase activity; antiischemic agents; treatment of cardiac infraction |
| 09/02/1997 | US5663380 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 09/02/1997 | US5663375 Cell proliferation |
| 09/02/1997 | US5663364 Heme binding compounds and use thereof |
| 09/02/1997 | US5663347 Regulators of cell proliferation and differentiation; treatment of skin disorders; anticarcinognic agents |
| 09/02/1997 | US5663345 Immunoregulatory, neuromuscular, joint and connective tissue disorders |
| 09/02/1997 | US5663334 Process for preparing pyrimidyl imidazoles |
| 09/02/1997 | US5663332 Method for the preparation of 3-hydroxy-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxy-phenyl)-1,5-benzothiazepine-4(5H)-one |
| 09/02/1997 | US5663191 Psychiatric diseases, anxiety and antidepressants |
| 09/02/1997 | US5663187 Treatment of atherosclerosis with angiotensin II receptor blocking imidazoles |
| 09/02/1997 | US5663186 Treatment of atherosclerosis with angiotensin II receptor blocking imidazoles |
| 09/02/1997 | US5663183 Cerebral disorders |
| 09/02/1997 | US5663173 Central nervous system disorders, cognition activators, pychoses, antidepressants and eating disorders |
| 09/02/1997 | US5663165 Hypolipidaemic benzothiazepine compounds |
| 09/02/1997 | US5663156 Mixture of higher primary aliphatic alcohols, its obtention from sugar cane wax and its pharmaceutical uses |
| 09/02/1997 | US5663151 Sulfated α-glycolipid derivatives as cell adhesion inhibitors |
| 09/02/1997 | US5663142 For treating thrombosis, protein s deficiency, sepsis, inflammation and cancer |
| 09/02/1997 | US5662934 Vitamins, gemfibrozil |
| 09/02/1997 | US5662930 Reduction of liposome-induced adverse physiological reactions |
| 09/02/1997 | US5662918 Bone disorders, storage stable |
| 09/01/1997 | CA2198687A1 Quinoxaline derivatives useful in therapy |
| 08/29/1997 | CA2198316A1 Treatment of septic shock with anti-tnf antibodies |
| 08/28/1997 | WO1997030677A2 Pentafluorobenzenesulfonamides and analogs |
| 08/28/1997 | WO1997019679A3 Use of nadph oxidase inhibitors for the manufacture of a medicament for prevention of atherosclerosis |
| 08/27/1997 | EP0791577A1 Ortho-substituted benzylguanidines, process for their preparation and their use as medicament or diagnostic agent as well as medicament containing them |
| 08/27/1997 | EP0791576A2 Leukotriene antagonistic benzoic acid derivatives |
| 08/27/1997 | EP0791360A2 Treatment of septic shock with anti-TNF antibodies |
| 08/27/1997 | EP0791355A1 Method of reducing tissue damage associated with ischemia |
| 08/27/1997 | EP0791009A1 Modified neuropeptide y receptors |
| 08/27/1997 | EP0791006A2 Polyanionic benzylglycosides as inhibitors of smooth muscle cell proliferation |
| 08/27/1997 | EP0791005A1 Smooth muscle cell proliferation inhibitors |
| 08/27/1997 | EP0791004A1 Acylated benzylglycosides as inhibitors of smooth muscle cell proliferation |
| 08/27/1997 | EP0790997A2 6-ARYL PYRIDO( 2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION |
| 08/27/1997 | EP0790994A1 Heterocycle substituted propenoic acid derivatives as nmda antagonists |
| 08/27/1997 | EP0790993A1 Nonpeptide endothelin antagonists |
| 08/27/1997 | EP0790987A1 Aminotetrazole derivatives useful as nitric oxide synthase inhibitors |
| 08/27/1997 | EP0790827A2 Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy |
| 08/27/1997 | EP0790826A1 Dihydropyrimidines and uses thereof |
| 08/27/1997 | EP0520005B1 Nitroxides for weight reduction |
| 08/27/1997 | CN1158144A Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 08/27/1997 | CN1158123A Benzoxazoles and pyridine derivatives useful in the treatment of the type II diabetes |
| 08/27/1997 | CN1157826A Novel, ubiquitous potassium-channel proteins and genes for the same |
| 08/27/1997 | CN1157822A Pharmaceutical compounds |
| 08/27/1997 | CN1157718A Method for reducing infarct size in subjects afflicted with ischemic heart disease |
| 08/26/1997 | US5661183 Prevention or treatment of neurodegeneration |
| 08/26/1997 | US5661178 Method for effecting vasodilation with (1,5-inter)aryl prostaglandin derivatives |
| 08/26/1997 | US5661174 Guanidinealkyl-1,1-bisphosphonic acid derivatives, process for their preparation and their use |
| 08/26/1997 | US5661173 Administering an enzyme inhibitor treating diabetes |
| 08/26/1997 | US5661169 1-benzyl-1,3-dihydro-2H-benzimidazol-2-one derivatives, their preparation and the pharmaceutical compositions containing them |
| 08/26/1997 | US5661168 Hypoglycemic agents |
| 08/26/1997 | US5661162 4-aminomethyl/thiomethyl/sulfonylmethyl-4-phenylpiperdines as tachykinin receptor antagonists |
| 08/26/1997 | US5661161 Administering to treat cancer in mammals |
| 08/26/1997 | US5661157 Annelated dihydropyridines and the use thereof for preparing pharmaceutical preparations |
| 08/26/1997 | US5661135 Human VEGF-specific oligonucleotides |
| 08/26/1997 | US5661129 Organic nitrates containing a disulfide group as cardiovascular agents |